Glaxo Wellcome S.A.

Poland

All drugs from this manufacturer

  • ADARTREL

    The medicine is used to treat moderate to severe restless legs syndrome (Ekbom syndrome). It helps relieve unpleasant sensations in the limbs and reduces the urge to move the legs or other parts of the body.

    Dosage form: tablets, film-coated

    Active substance Dosage
    ropinirole 0,250 mg

    ATC: N04BC04

  • The medicine is used to treat moderate to severe restless legs syndrome (Ekbom syndrome). It helps relieve unpleasant sensations in the legs and reduces the urge to move the limbs.

    Dosage form: tablets, film-coated

    Active substance Dosage
    ropinirole 0,50 mg

    ATC: N04BC04

  • The medicine is used to treat moderate to severe restless legs syndrome (Willis-Ekbom disease). It helps relieve unpleasant sensations in the legs and reduces the urge to move the limbs.

    Dosage form: tablets, film-coated

    Active substance Dosage
    ropinirole 2.00 g

    ATC: N04BC04

  • The medicine is used for the prevention and treatment of seasonal and perennial allergic rhinitis (including hay fever), as well as for the symptomatic treatment of nasal polyps. It helps to reduce swelling, irritation, itching, sneezing, and runny nose.

    Dosage form: spray, nasal suspension

    Active substance Dosage
    fluticasone propionate 0.05 g

    ATC: R01AD08

  • The medicine is intended for the treatment of arterial hypertension. It may be used alone or in combination with other blood pressure-lowering medicines.

    Dosage form: tablets, film-coated

    Active substance Dosage
    lacidipine 6 mg

    ATC: C08CA09

  • The medicine is used to treat Parkinson's disease. It helps relieve its symptoms by acting in the brain in a manner similar to naturally occurring dopamine.

    Dosage form: tablets, film-coated

    Active substance Dosage
    ropinirole hydrochloride 2 mg

    ATC: N04BC04

  • The medicine is used to treat Parkinson's disease. It helps relieve its symptoms by acting in the brain in a manner similar to naturally occurring dopamine.

    Dosage form: tablets, film-coated

    Active substance Dosage
    ropinirole hydrochloride 0.5 mg

    ATC: N04BC04

  • The medicine is used to treat Parkinson's disease. It helps relieve its symptoms by acting in the brain in a manner similar to naturally occurring dopamine.

    Dosage form: tablets, film-coated

    Active substance Dosage
    ropinirole hydrochloride 5 mg

    ATC: N04BC04

  • The medicine is used to treat Parkinson's disease. It helps relieve its symptoms by acting in the brain in a manner similar to naturally occurring dopamine.

    Dosage form: tablets, film-coated

    Active substance Dosage
    ropinirole hydrochloride 0.25 mg

    ATC: N04BC04

  • The medicine is used to treat Parkinson's disease. It helps relieve its symptoms by acting similarly to the dopamine naturally occurring in the brain.

    Dosage form: tablets, film-coated

    Active substance Dosage
    ropinirole hydrochloride 1 mg

    ATC: N04BC04

  • The medicine is used to treat Parkinson's disease. It helps relieve its symptoms by acting in a manner similar to the dopamine naturally occurring in the brain.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ropinirole hydrochloride 4 mg

    ATC: N04BC04

  • The medicine is used in the treatment of Parkinson's disease. It helps to relieve its symptoms by acting in the brain in a manner similar to naturally occurring dopamine.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ropinirole hydrochloride 8 mg

    ATC: N04BC04

  • The medicine is used to treat Parkinson's disease. It helps relieve its symptoms by acting in a manner similar to the dopamine naturally occurring in the brain.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ropinirole hydrochloride 2 mg

    ATC: N04BC04

  • The medicine is intended to facilitate smoking cessation in individuals who are also receiving motivational support, for example, as part of a therapeutic program.

    Dosage form: tablets, film-coated, prolonged release

    Active substance Dosage
    bupropion hydrochloride 150 mg

    ATC: N06AX12